Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders.

On Friday, I sat down with Dr. Ilya Gipp, oncology chief medical officer at GE HealthCare, for a fascinating conversation about theranostics. It's a timely topic, not only because theranostics is changing what's possible in cancer care, but because today is World Theranostics Day, celebrating the very first application of theranostics by Dr. Saul Hertz in 1941.

We talk about what we really mean when we talk about theranostics, how emerging applications are being developed, and the role theranostics will play in the future of cancer care.

Today, Ilya is at Willis Knighton Cancer Center in Shreveport, Louisiana, commemorating the grand opening of the Willis Knighton Nuclear Oncology Center, so we also discuss what it takes to bring these cutting-edge treatments to regular patients in the real world.

After listening to the interview, I highly recommend you read an article Ilya has written for HealthCare Business News. It provides a tidy summary on the evolution of theranostics and is a must-read for anyone who wants to better understand the trajectory of personalized cancer care.


We hope you enjoy the conversation. Please tell us what you think, and let us know who you would like to see interviewed next.